Pfizer eyes $10B-plus market for RSV vaccines with pandemic-era model (NYSE:PFE) Markets August 28, 2022 [ad_1] Pfizer (NYSE:PFE) made a significant step ahead final week to entry a market alternative price greater than $10B for…
